the results of the anturane reinfarction trial , a randomized , double-blind , multicenter clinical trial , represent the data on 1558 patients who received either sulfinpyrazone or placebo for an average of 16 months , starting 25 to 35 days after a documented myocardial infarction .
C0038742
sulfinpyrazone
C0027051
myocardial infarction